Full course description
This course addresses prevalence of psychiatric disorders and the use of psychotropic drugs. The students will be presented pharmacotherapeutic data of several drugs, necessary to start a therapeutic regimen for individual patients. Clinical pharmacological knowledge will be applied to several cases within different drug groups, i.e. cardiac and CNS drugs, with the objective to maximize drug effects while minimizing side effects (i.e. movement, cardiovascular, sexual and CNS side effects). The influence of genetic polymorphisms and drug-drug interactions on patient dependent drug choice and treatment adherence.
Students will be able to understand:
- the epidemiology of psychiatric diseases and CNS drugs in the general population;
- pharmacokinetic and pharmacodynamics properties of CNS drugs, including genetic polymorphisms;
- how to translate clinical pharmacological concepts into pharmacotherapy of psychiatric diseases.